Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumors of the Pancreas”

2,108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,108 results

Not applicableLooking for participantsNCT07250100
What this trial is testing

The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

Who this might be right for
Pancreatic CancerMicrobiome
Herlev Hospital 300
Not applicableActive Not RecruitingNCT02531607
What this trial is testing

Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

Who this might be right for
Pancreatic Neoplasms
AdventHealth 500
Testing effectiveness (Phase 2)WithdrawnNCT01600807
What this trial is testing

OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer, Metastatic
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00964171
What this trial is testing

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Bergonié 19
Not applicableStudy completedNCT06980792
What this trial is testing

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Who this might be right for
Pancreas NeoplasmsLiver MetastasisPancreas Ductal Adenocarcinoma+3 more
Azienda Ospedaliero-Universitaria di Modena 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207944
What this trial is testing

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Who this might be right for
IPMNIPMN, Pancreatic
Duke University 100
Not applicableLooking for participantsNCT05052671
What this trial is testing

CtDNA Assay in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreas Cancer
University of Oklahoma 50
Testing effectiveness (Phase 2)Study completedNCT00735917
What this trial is testing

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT00035035
What this trial is testing

Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Who this might be right for
Pancreatic NeoplasmsMetastases, Neoplasm
Eli Lilly and Company
Early research (Phase 1)Looking for participantsNCT05911217
What this trial is testing

Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CARsgen Therapeutics Co., Ltd. 20
Large-scale testing (Phase 3)UnknownNCT00689715
What this trial is testing

Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas

Who this might be right for
Cystic Tumors of the Pancreas
Asan Medical Center 50
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Early research (Phase 1)Study completedNCT02146313
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsOvarian Neoplasms
Genentech, Inc. 35
Testing effectiveness (Phase 2)UnknownNCT06395337
What this trial is testing

Multimodal Imaging in Rectal Cancer & Pancreatic Cancer

Who this might be right for
Rectal CancerPancreatic Cancer
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07296341
What this trial is testing

HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer With
Shanghai Hengrui Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT00907166
What this trial is testing

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

Who this might be right for
CancerPancreatic CancerPancreatic Carcinoma
Cornerstone Pharmaceuticals 6
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Large-scale testing (Phase 3)Study completedNCT03984214
What this trial is testing

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic
Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Early research (Phase 1)Ended earlyNCT06194877
What this trial is testing

Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Who this might be right for
Colorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
MapKure, LLC 13
Next Page